Orbera intragastric balloon aids weight loss and reduces cardiovascular riskIntragastric balloon therapy (IGBT) with the Orbera intragastric balloon (Apollo EndoSurgery) produces short-term weight reduction...
Orbera intragastric balloon aids weight loss and reduces cardiovascular riskIntragastric balloon therapy (IGBT) with the Orbera intragastric balloon (Apollo EndoSurgery) produces short-term weight reduction...
Apollo Endosurgery gains CPT Codes for use in intragastric balloon proceduresApollo Endosurgery has gained the assignment of Category I Current Procedural Terminology (CPT) codes with short form descriptor...
FDA grants Breakthrough Device Designation for Apollo’s Orbera Balloon for NASH treatmentApollo Endosurgery has received a Breakthrough Device Designation from the FDA for the Orbera Intragastric Balloon, specifically for the...
LSG and RYGB-induced upregulation of apoA-IV is beneficial for insulin secretion and energy expenditure18 hours ago
Tirzepatide reduced sleep apnoea severity by up to nearly two-thirds in adults living with OSA and obesity18 hours ago